longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Allmed Medical

002950

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Discovering Undiscovered Gems in Global for April 2026

    Simplywall·Apr 13 at 10:02 AM
    688610+1.81%002950+0.23%
  • A-share medical consumables stocks continue to rise, ZHYL and INTCO are approaching a 20% limit-up, Allmed Medical and BLUE SAIL MEDICAL previously hit the limit-up, Sanxin Medtec and CAINA have leading gains

    Wallstreetcn·Mar 13 at 05:43 AM
    301122+11.32%300453-0.65%
  • National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance

    36Kr·Jan 31 at 02:39 AM
    002038-0.17%512290-0.09%
  • Allmed Medical: Net profit in the third quarter was 149 million yuan, a year-on-year increase of 90.57%

    Zhitong·Oct 29, 2025 at 10:56 AM
    002950+0.23%
  • Allmed Medical: Chen Haohua has reduced his holdings by 1.89%

    Zhitong·Oct 16, 2025 at 12:57 PM
    002950+0.23%
  • Allmed Medical: Existing production capacity can meet market demand

    36Kr·Sep 26, 2025 at 02:51 AM
    002950+0.23%
  • Allmed Medical: Net profit of 200 million yuan in the first half of 2025, a year-on-year increase of 6.87%

    Zhitong·Aug 26, 2025 at 10:34 AM
    002950+0.23%
  • Allmed Medical shareholder Chen Haohua plans to reduce his holdings by no more than 3%

    Zhitong·Jun 25, 2025 at 12:36 PM
    002950+0.23%
  • Allmed: Net profit in the first quarter of 2025 was 86.5027 million yuan, a year-on-year decrease of 7.86%

    Zhitong·Apr 25, 2025 at 06:28 PM
    002950+0.23%
  • Allmed: In 2024, the net profit is 369 million yuan, a year-on-year increase of 233.95%

    Zhitong·Apr 25, 2025 at 06:28 PM
    002950+0.23%
  • Allmed issued a profit forecast, expecting an annual net profit of 305 million to 355 million yuan, a year-on-year increase of 176.27%—221.56%

    Zhitong·Jan 24, 2025 at 03:07 PM
    002950+0.23%
  • Allmed: The net profit for 2024 is expected to grow by 176.27% - 221.56% year-on-year

    Zhitong·Jan 24, 2025 at 10:26 AM
    002950+0.23%
  • 28 companies disclosed their repurchase progress, with FOSUN PHARMA, Allmed, and NHD having the highest repurchase plan amounts

    Zhitong·Jan 22, 2025 at 11:55 PM
    600196+0.35%02196-1.09%
  • Allmed plans to repurchase company shares for between 50 million and 100 million yuan

    Zhitong·Jan 22, 2025 at 01:15 PM
    002950+0.23%